Megan Murray is a Professor of Epidemiology at the Harvard School of Public Health where she leads a research team Which conducts multidisciplinary research on MDR and XDR TB Involving conventional and molecular epidemiology, cost-effectiveness and mathematical modeling, and operations research outcomes, and genomic epidemiology . Also Dr. Murray is an Associate Professor of Medicine and the Director of Research at the Brigham and Women's Hospital Division of Global Health Equity and its sister organizaciones, Partners In Health and the Department of Global Health and Social Medicine at Harvard Medical School.
Dr. Murray's research group has the Following major areas of interest:
1. Epidemiology and transmission dynamics of drug sensitive and resistant tuberculosis
Two. Evolution and within-host dynamics of drug resistant M. tuberculosis
Three. Host susceptibility iron metabolism and TB
April. Social, economic and biologic determinants of tuberculosis
May. Methodological Approaches to evaluation of the impact of global health interventions
An integrated approach to MS research and care: the 2007 John Dystel Prize for Multiple Sclerosis for Dr. Howard L. Weiner.(SPECIAL RESEARCH ISSUE): An article from: Inside MS
Book (Thomson Gale)
Harvard2011-05-29 13:25:53 by Otto_Negme
Statement Concerning the Outcome of the Review Into Allegations of Research Misconduct Involving Fluoride Research
BOSTON-August 15, 2006-"The Harvard Medical School and School of Dental Medicine (HSDM) review of Chester Douglass, DMD, PhD, professor of oral health policy and epidemiology at HSDM, has concluded that Douglass did not intentionally omit, misrepresent, or suppress research findings of a graduate student surrounding federal grant work looking at potential links between fluoride in drinking water and osteosarcoma, a form of bone cancer.
"An Inquiry Panel and the Standing Committee on Faculty Conduct, both comprised of senior faculty from a range of fields, each conducted reviews and found that Douglass did not commit research misconduct
I was a Faculty Research Assistant at the Univ2006-12-29 23:04:23 by milliemae
RO-1 budget cuts and never finished the Ph.D. which leaves me screwed. I have 14 years of Biochemistry / Cell Biology experience including Harvard Medical School and Millennium Pharma Inc. I originally came out here for a Ph.D program in Wine Making and Vine Growth, I hated my advisor, loved Corvallis and the U. but, it's all soft money. I am looking in Salem and I could go up to Portland and I have a really great childhood friend there too but, it's not so simple. I have 5 adopted dogs and it would be VERY hard to find a place to rent in any city and so I really would have to buy and sell a home, not so much for me but for them
I don't claim to be a scientist, i am a2011-02-22 05:38:48 by FriendofFargo
Scientist - undergrad Columbia U, Ph D oxford - five years Merck sharp and Dohme research labs with 3 patents and then 15 years faculty Harvard medical school
I'm retired but i continue to collaborate with my co-principal investigator at harvard - currently on aquaporins
Your opinions on what scientists think are ridiculous. You don't know anything but are arrogant because you feel your religion gives you a license to comment on areas where you KNOW NOTHING.
Find me these "scientists" who reject evolution for SCIENTIFIC REASONS and not religious ones.
You might also like:
USAMRIID scientists closer to cure for Ebola virus, new study says — Frederick News Post
In a study led by the U.S. Army Medical Research Institute for Infectious Diseases and published in Science Translational Medicine, 43 percent, or three out of seven infected monkeys, recovered in 104 to 120 hours after intravenous treatment.
Texas A&M Research Aids Military in Fighting Brucellosis on the Battlefield — KBTX
She will continue to contribute to ongoing projects with U.S. Army Medical Research Institute of Infectious Diseases for controlled release viral vaccines.